Senzime
4,95
SEK
-3,88 %
Mindre end 1K følgere
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-3,88%
-4,26%
-16,53%
-10%
-17,36%
-20,55%
-74,13%
-70,82%
-16,59%
Senzime operates in the medical technology industry and focuses on the development and manufacture of systems for monitoring and diagnostics in healthcare. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. The company's products are aimed at healthcare institutions and physicians. The operations are global. Senzime was founded in 1999 and is headquartered in Uppsala, Sweden.
Læs mereMarkedsværdi
659,41 mio. SEK
Aktieomsætning
1,46 mio. SEK
Omsætning
58,48 mio.
EBIT %
-212,12 %
P/E
-
Udbytteafkast, %
-
Finanskalender
19.5
2025
Generalforsamling '25
27.8
2025
Delårsrapport Q2'25
7.11
2025
Delårsrapport Q3'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Senzime secures new system-wide contract with major Pacific northwest US healthcare system
Carnegie Access: Senzime: Confidence builder – Q1(25) review
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools